Results 1 to 10 of about 2,598,104 (298)
Acknowledgement to Reviewers of Antibodies in 2018
Peer review is an essential part of the publication process, ensuring that Antibodies maintains high quality standards for its published papers. [...]
Antibodies Editorial Office
doaj +2 more sources
Acknowledgement to Reviewers of Antibodies in 2013
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Antibodies Editorial Office
doaj +2 more sources
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling +6 more
doaj +1 more source
Single-Cell Technologies for the Study of Antibody-Secreting Cells
Antibody-secreting cells (ASC), plasmablasts and plasma cells, are terminally differentiated B cells responsible for large-scale production and secretion of antibodies.
Matteo Broketa +2 more
doaj +1 more source
Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems.
Dubravka Drabek +7 more
doaj +1 more source
Therapeutic antibodies (Abs) which act on a broader range of epitopes may provide more durable protection against the genetic drift of a target, typical of viruses or tumors.
Ilse Roodink +20 more
doaj +1 more source
Serum amyloid A (SAA) proteins belong to a family of acute-phase reactants, playing an integral role in defending the organism from pathological damage.
Ralfs Buks +6 more
doaj +1 more source
Acknowledgement to Reviewers of Antibodies in 2017
Peer review is an essential part in the publication process, ensuring that Antibodies maintains high quality standards for its published papers.[...]
Antibodies Editorial Office
doaj +1 more source
How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
Following the administration of immune checkpoint inhibitors, an unexpected pattern of response designated as hyperprogression may be observed in certain patients.
Morgane Denis +6 more
doaj +1 more source
In developing therapeutic antibodies, the heavy chain is often prioritised due to its higher variability and its central role in antigen binding. An appropriate pairing of the light sequence is however important for antibody function.
Henriette L. Capel +11 more
doaj +1 more source

